A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the rate of kidney or heart impairment, if any, in
subjects who received BMS-986094 (INX-08189) in Phase 1 clinical trials